Hancom MDS Inc (086960) — Capital Reinvestment Ratio
Hancom MDS Inc (086960) has a Capital Reinvestment Ratio of 0.10x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩8.59 Billion) in capital expenditures (₩900.67 Million). See Hancom MDS Inc net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hancom MDS Inc Capital Reinvestment Ratio (2007–2024)
This chart tracks Hancom MDS Inc's Capital Reinvestment Ratio across 13 annual periods. Check 086960 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Hancom MDS Inc (2007–2024)
Year-by-year Capital Reinvestment Ratio for Hancom MDS Inc from 2007 to 2024. For live market cap and broader valuation context, see market cap of Hancom MDS Inc.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.49x | ₩2.90 Billion | ₩1.42 Billion | ▲ +1514.7% |
| 2023 | 0.03x | ₩26.32 Billion | ₩798.10 Million | ▼ -93.2% |
| 2021 | 0.45x | ₩2.83 Billion | ₩1.27 Billion | ▲ +22.0% |
| 2020 | 0.37x | ₩6.78 Billion | ₩2.48 Billion | ▼ -17.7% |
| 2019 | 0.44x | ₩4.95 Billion | ₩2.20 Billion | ▲ +146.7% |
| 2018 | 0.18x | ₩20.47 Billion | ₩3.69 Billion | ▼ -45.1% |
| 2017 | 0.33x | ₩3.57 Billion | ₩1.17 Billion | ▼ -54.3% |
| 2015 | 0.72x | ₩6.27 Billion | ₩4.50 Billion | ▲ +393.2% |
| 2014 | 0.15x | ₩12.73 Billion | ₩1.85 Billion | ▼ -45.1% |
| 2013 | 0.27x | ₩12.06 Billion | ₩3.20 Billion | ▼ -71.4% |
| 2012 | 0.93x | ₩6.63 Billion | ₩6.17 Billion | ▲ +563.2% |
| 2011 | 0.14x | ₩4.76 Billion | ₩667.39 Million | ▲ +4.5% |
| 2007 | 0.13x | ₩7.05 Billion | ₩946.15 Million | — |